1245 Th17 and Type 2 CD8+ cytokine signatures predict irAEs in solid tumors

Ítems similars

• 1245 Th17 and Type 2 CD8+ cytokine signatures predict irAEs in solid tumors
  per: Evan J Lipson, et al.
  Publicat: (2023-11-01)
• Immune-related events in individuals with solid tumors on immunotherapy associate with Th17 and Th2 signatures
  per: Chester J. Kao, et al.
  Publicat: (2025-03-01)
• Immune-related events in individuals with solid tumors on immunotherapy associate with Th17 and Th2 signatures
  per: Chester J. Kao, et al.
  Publicat: (2025-03-01)
• Age-related divergence of circulating immune responses in patients with solid tumors treated with immune checkpoint inhibitors
  per: Chester Kao, et al.
  Publicat: (2025-04-01)
• Entinostat in combination with nivolumab for patients with advanced cholangiocarcinoma: a phase 2 clinical trial
  per: Elsa Hallab, et al.
  Publicat: (2025-07-01)